Kidney Transplant Phase 3 Belatacept BENEFIT Report for Patients Like You : PatientsLikeMe

Skip over navigation

Filter by:

All
Start typing to see suggestions

patients

Home > Community Treatment Reports and Side Effects > Kidney Transplant Phase 3 Belatacept BENEFIT Treatment Report

You appear to have JavaScript disabled in your browser. PatientsLikeMe relies on JavaScript and Cookies to deliver the best possible experience to you. How do I enable JavaScript?

What is Kidney Transplant Phase 3 Belatacept BENEFIT?

NCT00256750 is belatacept evaluation of nephroprotection and efficacy as first-line immunosuppression trial. Other study IDs include: IM103-008, BENEFIT.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose	# of patients	# of patients with evaluations Efficacy	Major	Moderate	Slight	None	Can’t tell
Transplant rejection prevention	1	1

See 1 patient currently using Kidney Transplant Phase 3 Belatacept BENEFIT

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe	0
Moderate	0
Mild	0
None	1

Reported Schedules

	750 mg monthly
	1

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Kidney Transplant Phase 3 Belatacept BENEFIT

Always	1	100%
Usually	0	0%
Sometimes	0	0%
Never	0	0%

Burden

Difficulty being on treatment

Burden of Kidney Transplant Phase 3 Belatacept BENEFIT

Very	0	0%
Somewhat	0	0%
A little	0	0%
Not at all	1	100%

Cost

Paid out of pocket

Cost of Kidney Transplant Phase 3 Belatacept BENEFIT

$200+	0	0%
$100-199	0	0%
$50-99	0	0%
$25-49	0	0%
< $25	1	100%

Report created on May 23, 2012.